807
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Visit-to-visit ultrafiltration volume variability predicts all-cause mortality in patients receiving hemodialysis

, , , , , , , , ORCID Icon & show all
Article: 2194439 | Received 04 Nov 2022, Accepted 18 Mar 2023, Published online: 03 Apr 2023

References

  • Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol. 2022;18(6):378–395.
  • Okpechi IG, Jha V, Cho Y, et al. The case for increased peritoneal dialysis utilization in low- and lower-middle-income countries. Nephrology. 2022;27(5):391–403.
  • Ma L, Zhao S. Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. Int J Cardiol. 2017;238:151–158.
  • Loutradis C, Sarafidis PA, Ferro CJ, et al. Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management. Nephrol Dial Transplant. 2021;36(12):2182–2193.
  • Kalantar-Zadeh K, Lockwood MB, Rhee CM, et al. Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat Rev Nephrol. 2022;18(3):185–198.
  • Zoccali C, Mallamaci F. Mapping progress in reducing cardiovascular risk with kidney disease: managing volume overload. Clin J Am Soc Nephrol. 2018;13(9):1432–1434.
  • Ok E, Asci G, Chazot C, et al. Controversies and problems of volume control and hypertension in haemodialysis. Lancet. 2016;388(10041):285–293.
  • Canaud B, Chazot C, Koomans J, et al. Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities. J Bras Nefrol. 2019;41(4):550–559.
  • Keane DF, Raimann JG, Zhang H, et al. The time of onset of intradialytic hypotension during a hemodialysis session associates with clinical parameters and mortality. Kidney Int. 2021;99(6):1408–1417.
  • Ohashi Y, Sakai K, Hase H, et al. Dry weight targeting: the art and science of conventional hemodialysis. Semin Dial. 2018;31:551–556.
  • Kramer H, Yee J, Weiner DE, et al. Ultrafiltration rate thresholds in maintenance hemodialysis: an NKF-KDOQI controversies report. Am J Kidney Dis. 2016;68(4):522–532.
  • Lee Y, Okuda Y, Sy J, et al. Ultrafiltration rate effects declines in residual kidney function in hemodialysis patients. Am J Nephrol. 2019;50(6):481–488.
  • Slinin Y, Babu M, Ishani A. Ultrafiltration rate in conventional hemodialysis: where are the limits and what are the consequences? Semin Dial. 2018;31(6):544–550.
  • K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl. 3):S1–S153.
  • Loutradis CN, Tsioufis C, Sarafidis PA. The clinical problems of hypertension treatment in hemodialysis patients. Curr Vasc Pharmacol. 2017;16(1):54–60.
  • Loutradis C, Sarafidis PA, Papadopoulos CE, et al. The Ebb and flow of echocardiographic cardiac function parameters in relationship to hemodialysis treatment in patients with ESRD. J Am Soc Nephrol. 2018;29(5):1372–1381.
  • Ozdogan O, Kayikcioglu M, Asci G, et al. Left atrial volume predicts mortality in low-risk dialysis population on long-term low-salt diet. Am Heart J. 2010;159(6):1089–1094.
  • Sarafidis PA, Kamperidis V, Loutradis C, et al. Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes? Nephrol Dial Transplant. 2017;32(8):1402–1409.
  • Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24(5):1574–1579.
  • Munoz Mendoza J, Sun S, Chertow GM, et al. Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant. 2011;26(4):1281–1287.
  • Zoccali C, Torino C, Tripepi R, et al. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol. 2013;24(4):639–646.
  • Amari Y, Morimoto S, Iida T, et al. Characteristics of visit-to-visit blood pressure variability in hemodialysis patients. Hypertens Res. 2019;42(7):1036–1048.
  • Huang JT, Cheng HM, Yu WC, et al. Increased nighttime pulse pressure variability but not ambulatory blood pressure levels predicts 14-year all-cause mortality in patients on hemodialysis. Hypertension. 2019;74(3):660–668.
  • Liao R, Li J, Lin L, et al. The association between long- and intra-dialytic blood pressure variability with all-cause mortality in hemodialysis patients. Blood Purif. 2019;48(1):43–50.
  • Zhao Y, Yang L, Yu S, et al. Blood pressure variability and prognosis in hemodialysis patients: a systematic review and meta-analysis. Kidney Dis. 2021;7(5):411–424.
  • Yang J, Huang J, Yu B, et al. Long-term predialysis blood pressure variability and outcomes in hemodialysis patients. J Clin Hypertens. 2022;24(2):148–155.
  • Zhu M, Dou L, Zhu M, et al. Variability of serum phosphorus and its association with mortality among hemodialysis patients. Clin Nephrol. 2018;90(2):79–86.
  • Chen C, Zhang J, Zhou Z, et al. Impact of serum albumin level and variability on short-term cardiovascular-related and all-cause mortality in patients on maintenance hemodialysis. Medicine. 2021;100(43):e27666.
  • Lin FJ, Zhang X, Huang LS, et al. Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients. Int Urol Nephrol. 2018;50(9):1703–1712.
  • Chang YM, Huang YT, Chen IL, et al. Heart rate variability as an independent predictor for 8-year mortality among chronic hemodialysis patients. Sci Rep. 2020;10(1):881.
  • Habib AN, Baird BC, Leypoldt JK, et al. The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2006;21(10):2881–2892.
  • João Matias P, Azevedo A, Laranjinha I, et al. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients. Blood Purif. 2014;38(3–4):244–252.
  • Moradi H, Streja E, Kashyap ML, et al. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2014;29(8):1554–1562.
  • Park KS, Ryu GW, Jhee JH, et al. Serum ferritin predicts mortality regardless of inflammatory and nutritional status in patients starting dialysis: a prospective cohort study. Blood Purif. 2015;40(3):209–217.